Macquarie Group’s QIAGEN NV QGENF Stock Holding History

Macquarie Group’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2	Closed	-$1K	–	1634
2016 Q2	$1K	Buy	+2	New	+$1K	﹤0.01%	1561
2015 Q3	–	Sell	-16,100	Closed	-$399K	–	1697
2015 Q2	$399K	Buy	+16,100	New	+$399K	﹤0.01%	1336
2015 Q1	–	Sell	-89	Closed	-$2K	–	1663
2014 Q4	$2K	Buy	+89	New	+$2K	﹤0.01%	1558

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Macquarie Group's QGENF Position: Q3 2016 in Review

Macquarie Group sold out of QIAGEN NV (QGENF) in Q3 2016, closing a stake of 2 shares — an estimated $1K sold.

Macquarie Group first reported a position in QGENF in Q4 2014 and held it in 3 quarters. The position peaked at $399K in Q2 2015. 210 funds tracked by Wall St. Rank hold QGENF as of Q3 2016.

Macquarie Group reported no remaining QIAGEN NV position as of Q3 2016 after selling out during the quarter.
Macquarie Group sold 2 QIAGEN NV shares in Q3 2016, an estimated $1K.
Macquarie Group first reported a position in QIAGEN NV in Q4 2014 and held it in 3 quarters.
Macquarie Group's QIAGEN NV position peaked at $399K in Q2 2015.
210 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2016.

Based on Macquarie Group's 13F filing for Q3 2016, filed 15 Nov 2016.